Patents
Patents for C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
05/2009
05/19/2009CA2209167C Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
05/14/2009US20090124800 process for the preparation of [1,4,5]-oxadiazepine derivatives
05/14/2009US20090124614 Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders
04/2009
04/29/2009EP1838683B1 A process for the preparation [1,4,5]-oxadiazepine derivatives
04/22/2009EP1715883B1 18-membered nitrobenzyl-substituted and aminobenzyl-substituted cyclohexadepsipeptides for controlling endoparasites, and method for the production thereof
04/15/2009EP2046761A2 Macrocyclic compounds useful as bace inhibitors
04/15/2009EP1711470B1 Malonamide derivatives blocking the activtiy of gamma-secretase
04/08/2009EP2044004A2 Benzamide derivatives as modulators of 11beta-hsd1 for treating diabetes and obesity
04/08/2009CN101405276A Compositions and methods for the inhibition of phospholipase A2
04/02/2009DE102008047409A1 Storing holographic data, comprises providing holographic storage medium comprising optically transparent substrate (photochemically active polynitrone dye) and irradiating transparent substrate with holographic interference pattern
03/2009
03/26/2009WO2009037642A1 Heterocyclic scaffolds useful for preparation of combinatorial libraries, libraries and methods of preparation thereof
03/25/2009CN101395143A Aza heterocyclics for the treatment of malaria or aids
03/25/2009CN101391953A Preparation of arthropodicidal oxadiazines
03/18/2009EP0872481B1 Depsipeptide derivative, process for production thereof, and novel intermediate therefor
03/04/2009EP2029611A2 17-desmethylrapamycin and analogues thereof, methods for their production and their use as immunosupressants, anticancer agents, antifungal agents etc.
02/2009
02/26/2009WO2008138527A3 Novel oxime compounds and the use thereof as anti-fouling agents
02/24/2009US7494990 2-(piperidin-4-yl)-4,5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors
02/03/2009US7485725 Substituted pyridines
02/03/2009US7485722 E.g., 3-(2'-Morpholin-4-ylmethyl-biphenyl-4-ylmethyl)-1-oxa-3-aza-spiro[4.5]decan-2-one; acute and chronic neurological and psychiatric disorders and chronic and acute pain disorders; Alzheimer's disease; schizophrenia; antidepressants; bipolar disorders; antiischemic agents; cardiotonic agents
01/2009
01/27/2009US7482364 Histamine H3 antagonists; do not contain imidazolyl moiety; such as 1-[4-(4-piperidin-1-ylmethyl-phenyl)-but-3-ynyl]-piperidine
01/21/2009EP0958291B1 3-heterocyclyl-substituted benzoyl derivatives
01/20/2009US7479573 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell
01/08/2009US20090012070 Pesticidal heterocycles
12/2008
12/31/2008EP1561820B1 Anthelmintic substance fki-1033 and process for producing the same
12/30/2008US7470817 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried
12/30/2008CA2143045C Lactic-acid-containing cyclic depsipeptides having 18 ring atoms as endoparasiticidal agents, and process for their preparation
12/24/2008EP2004642A1 Bifunctional polyazamacrocyclic chelating agents
12/24/2008EP1937651B1 Nnrt inhibitors
12/24/2008CN100445273C Calixarene aza-crown ether derivative, its preparation and use as metal ion fluorescent identification agent
12/17/2008CN100443463C Substituted p-trifluoromethyl phenyl ether compound and its prepn and application
12/11/2008US20080306259 Hydroxylation of beta-dicarbonyls with zirconium catalysts
12/11/2008US20080305955 Spiroketal-Substituted Cyclic Ketoenols
12/03/2008CN100439320C Intermediates for preparation of arthropodicidal oxadiazines
11/2008
11/27/2008US20080293702 Nitric Oxide Enhancing Pyruvate Compounds, Compositions and Methods of Use
11/27/2008US20080290034 Bridged macrocyclic module compositions
11/25/2008US7456163 Macrocycles useful in the treatment of alzheimer's disease
11/20/2008WO2008138527A2 Novel oxime compounds and the use thereof as anti-fouling agents
11/18/2008CA2278331C 3-heterocyclyl-substituted benzoyl derivatives
11/05/2008CN100430373C Biological active compound of methoxy acrylic ester containing bis trifluoromethyl phenyl and preparing process thereof
11/04/2008US7446104 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia
10/2008
10/30/2008WO2008130464A1 Macrocyclic ghrelin receptor modulators and methods of using the same
10/30/2008US20080269479 Process for Isolation of Macrolide Compounds
10/30/2008CA2677399A1 Macrocyclic ghrelin receptor modulators and methods of using the same
10/28/2008US7442691 Macrocycles useful in the treatment of alzheimer's disease
10/23/2008WO2008125201A1 Radiation-crosslinking and thermally crosslinking pu systems comprising iminooxadiazinedione
10/23/2008CA2683901A1 Radiation-crosslinking and thermally crosslinking pu systems comprising iminooxadiazinedione
10/21/2008CA2296012C Epothilone derivatives
10/16/2008US20080255087 Use of indolocarbazole antibiotic K252a derivatives as ERK inhibitors; amidation of K252a derivatives
10/15/2008CN101287731A Dioxazine- and oxdiazine-substituted arylamides
10/07/2008CA2272755C A process for preparing polyisocyanates containing iminooxadiazinedione groups
10/02/2008WO2008116302A1 Cathepsin cysteine protease inhibitors
10/01/2008EP1973887A1 Aza heterocyclics for the treatment of malaria or aids
10/01/2008CN101274917A Electroactive group-containing poly(aryl ether ketone)/polyether sulfone cyclic oligomer and preparation thereof
09/2008
09/24/2008CN101273020A NNRT inhibitors
09/18/2008WO2008110583A1 Amide compounds and their use as antitumor agents
09/18/2008CA2677874A1 Amide compounds and their use as antitumor agents
09/10/2008EP1966169A2 Compositions and methods for the inhibition of phospholipase a2
09/04/2008US20080214526 Macrocyclic Compounds and Compositions Useful as Bace Inhibitors
09/04/2008US20080214427 Using polymeric structure of sugar based polyols and other polyols as starting materials for attachment of organic bleach catalysts; benefits in detergents such as soil suspension, bleaching action and increased surfactant availability in the presence of free hardness
09/04/2008US20080214426 Alkoxylated polyol containing bleach activating terminating functional groups
08/2008
08/26/2008US7417057 insecticides; safe for crops; Fused partially unsaturated carbocyclic or heterocyclic ring substituted with a 5-or 6-membered heterocyclic ring such as imidazole, thiazole, oxazole, 1,3,4-oxadiazole
08/19/2008US7414157 Hydroxylation of β-dicarbonyls with zirconium catalysts
08/14/2008US20080194535 2-ethyl-hexanoic acid ((1S,4R,5S,8S,14R)-5-benzyl-4-hydroxy-18-methoxy-7-oxo-13-oxa-2,6-diaza-tricyclo[12.6.1.015,20]henicosa-10, 15(20),16,18-tetraen-8-yl)-methyl-amide; Alzheimer's Disease, Down's Syndrome; inhibitors of beta-secretase processing of amyloid precursor proteins
08/13/2008CN101239955A Method for producing fungicide composition
08/07/2008US20080188638 Heterobifunctional poly(ethyleneglycol) containing acid-labile amino protecting groups and uses thereof
08/07/2008US20080188468 Substituted Para-Trifluoromethyl Phenylate Compounds And Its Preparation And Use Thereof
08/07/2008US20080188371 use as pesticides and/or herbicides and/or microbicides; for the selective control of weeds; synergistic; low application rates and concentrations; in particular in cereals (especially wheat)
08/05/2008US7407917 Oil additive compound is the reaction product of a linear or branched, saturated or unsaturated monovalent aliphatic acid having 8 to 22 carbon atoms, urea, and polyalkylenepolyamine; non-borated and/or borated; reducing shudder in internal combustion engines; high torque transmissive capacity
07/2008
07/24/2008US20080176915 Substituted Benzo[d]isoxazol-3-yl Amine Compounds as Analgesics
07/23/2008EP1389223B1 Method for producing polyisocyanates
07/23/2008CN101228171A Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase
07/22/2008US7402579 Quinobenzoxazine analogs and compositions
07/15/2008CA2290176C New urethane acrylates and their use in coating compositions
07/10/2008US20080167444 Abc Transporter Inhibitor
07/09/2008EP1276729B1 New neurokinin antagonists for use as medicaments
07/08/2008CA2582172C Preparation of arthropodicidal oxadiazines
07/03/2008US20080161554 Macrocyclic carbodiimides (MC-CDI) and their derivatives, syntheses and applications of the same
07/02/2008EP1937651A1 Nnrt inhibitors
06/2008
06/25/2008CN101205187A Substituted aryl ethers compounds as well as preparation and uses thereof
06/11/2008CN100393741C Compounds with anti-inflammatory activity
06/10/2008US7384936 Carboxamidine derivatives and their use in the treatment of vascular diseases
06/04/2008EP1926728A1 Dioxazine- and oxadiazine-substituted arylamides
06/03/2008US7381730 Bone disorders, cardiovascular diseases, anticholesterol agents, hypertriglyceridemia, vasomotor disorders, urogenital disorders, prostatic hypertrophy, endometrial hyperplasia, anticarcinogenic agents; CNS disorders; side effect reduced
05/2008
05/28/2008EP1660884A4 Crown ether derivatives
05/28/2008CN101186596A Novel compound tatarine D and separating identification method thereof
05/22/2008US20080119395 Novel Depsipeptides and Process for Preparing Same
05/13/2008US7371853 Ring structuresC6.C6.C14N2O, C6.C6.C15N2O, C6.C6.C16N2O and C6.C6.C17N2O
05/01/2008US20080103135 Histamine H3 antagonists; do not contain imidazolyl moiety; such as 1-[4-(4-piperidin-1-ylmethyl-phenyl)-but-3-ynyl]-piperidine
05/01/2008US20080102031 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H,1-benzopyran-2,4'-piperidine; ligands of delta opioid receptor; analgesic, anxiolitic, antidepressant, analgesic; gastrointestinal disorders, neurodegenerative diseases; side effect reduction
04/2008
04/30/2008CN100384834C Epothilone derivatives
04/24/2008US20080096876 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia
04/23/2008EP1054875B1 Insecticidal dihydro-oxadiazines, -thiadiazines and -triazines
04/23/2008CN101165048A Method for preparing polyisocyanic acid ester
04/15/2008US7358239 Treating impaired fundic relaxation; [1(R),[A-(3 alpha ,4 alpha )]]-1-[1-[(3,4-dihydro-2H-1-benzopyran-2-yl)methyl]-3-methoxy-4-piperidinyl]-2(1H)-pyrimidinone
04/09/2008EP1907392A1 Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase
04/09/2008CN101157713A Application of aza crown ether complex as nucleic acid cutting reagent
04/08/2008US7355042 Sleep disorders; side effect reduction
03/2008
03/20/2008WO2008009750A3 Macrocyclic compounds useful as bace inhibitors
03/20/2008US20080070898 Sodium channel inhibitor of low side effect; analgesics; neuropathic pain; 4-(2-{4-[(E)-2-(2-methylphenyl)vinyl]piperidin-1-yl}-2-oxoethyl)morpholine for example
03/20/2008US20080070885 disorders related to beta-amyloid such as Alzheimer's disease, Down's Syndrome, memory and cognitive impairment, dementia, amyloidosis; (2R,4S) N-Butyl-4-hydroxy-2-methyl-4-((10S,13S)-10-methyl-8,11-dioxo-2-oxa-9,12-diaza-bicyclo[13.3.1]nonadeca-1(18),15(19),16-trien-13-yl)-butyramide for example
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 24